Actualités Caraco Pharmaceutical Laboratories, Ltd. Common Stock - CPD | Actions American Stock Exchange

- Amended Statement of Beneficial Ownership (SC 13D/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of...

- Notification that Annual Report will be submitted late (NT 10-K)

United States Securities and Exchange Commission Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Amendment No. 0...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13...

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (§240.13e-100) RULE 13e-3 TRANSACTION...

Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger

Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger PR Newswire DETROIT, June 14, 2011...

- Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (§240.13e-100) RULE 13e-3 TRANSACTION STATEMENT...

- Proxy Soliciting Materials (revised) (PRER14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (§240.13e-100) RULE 13e-3 TRANSACTION STATEMENT...

- Proxy Soliciting Materials (revised) (PRER14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...

- Statement of Ownership: Private Transaction (SC 13E3)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (§240.13e-100) RULE 13e-3 TRANSACTION...

- Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...

- Amended Statement of Beneficial Ownership (SC 13D/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d...

Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share

Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share PR Newswire DETROIT, Feb. 22, 2011...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Caraco Pharmaceutical Laboratories, Ltd. Common Stock (CPD)

Outils de qualité professionnelle, pour des investisseurs individuels.

CPD Actualités

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Notification that Annual Report will be submitted late (NT 10-K)

- Current report filing (8-K)

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger

- Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

- Proxy Soliciting Materials (revised) (PRER14A)

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

- Proxy Soliciting Materials (revised) (PRER14A)

- Statement of Ownership: Private Transaction (SC 13E3)

- Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Current report filing (8-K)

Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Caraco Pharmaceutical Laboratories, Ltd. Common Stock (CPD) Actualités

Caraco Pharmaceutical Laboratories, Ltd. Common Stock (CPD)

Outils de qualité professionnelle, pour des investisseurs individuels.

CPD Actualités

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Notification that Annual Report will be submitted late (NT 10-K)

- Current report filing (8-K)

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger

- Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

- Proxy Soliciting Materials (revised) (PRER14A)

- Amended Statement of Ownership: Private Transaction (SC 13E3/A)

- Proxy Soliciting Materials (revised) (PRER14A)

- Statement of Ownership: Private Transaction (SC 13E3)

- Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Current report filing (8-K)

Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application